Abiopharma

🔍 Ramachandran Ramesh (Executive)

Company: Ocugen, Inc. (OCGN)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 207,300 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 209,100.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 310,950 shares of Option (Right to Buy) at $1.38 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 310,950.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest annually in three equal installments commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates.
• F2: The option vests annually in equal installments over three years commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates.